What does Abeona Therapeutics Inc. do?
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also…
What is Abeona Therapeutics Inc.'s P/E and P/B ratio?
Abeona Therapeutics Inc. has a P/E ratio of -3.8 and a P/B ratio of 2.00.
What is Abeona Therapeutics Inc.'s debt-to-equity ratio?
Abeona Therapeutics Inc. has a debt-to-equity ratio of 0.16.
How much does Abeona Therapeutics Inc. owe compared with what it owns?
Abeona Therapeutics Inc. owes $0.29 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Abeona Therapeutics Inc.'s Positivity rank?
Abeona Therapeutics Inc. is ranked #3,659 of 6,774 companies globally and #1,630 of 4,000 in United States on PositoAI, with a Positivity Score of 20,360.
Does Abeona Therapeutics Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Abeona Therapeutics Inc..
Where can I read the latest news about Abeona Therapeutics Inc.?
Recent headlines about Abeona Therapeutics Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Abeona Therapeutics Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Abeona Therapeutics Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.